Literature DB >> 17161287

Metoprolol treatment decreases tissue myeloperoxidase activity after spinal cord injury in rats.

H Beril Gok1, Ihsan Solaroglu, Ozerk Okutan, Behzat Cimen, Erkan Kaptanoglu, Selcuk Palaoglu.   

Abstract

Neutrophil infiltration has been reported to play an important role in spinal cord injury (SCI). In addition to their cardioprotective effects, beta-blockers have been found to have neuroprotective effects on the central nervous system, but their effect on SCI has not yet been studied. In the current study, we investigated the effect of metoprolol on myeloperoxidase (MPO) activity, a marker of neutrophil activation, in the spinal cord after experimental SCI in rats. Rats were divided into six groups: controls received only laminectomy and spinal cord samples were taken immediately; the sham operated group received laminectomy, and spinal cord samples were taken 4h after laminectomy; the trauma only group underwent a 50g/cm contusion injury but received no medication; and three other groups underwent trauma as for the trauma group, and received 30mg/kg methylprednisolone, 1mg/kg metoprolol, or 1mL saline, respectively. All the medications were given intraperitoneally as single doses, immediately after trauma. Spinal cord samples were taken 4h after trauma and studied for MPO activity. The results showed that tissue MPO activity increased after injury. Both metoprolol and methylprednisolone treatments decreased MPO activity, indicating a reduction in neutrophil infiltration in damaged tissue. The effect of metoprolol on MPO activity was found to be similar to methylprednisolone. In view of these data, we conclude that metoprolol may be effective in protecting rat spinal cord from secondary injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17161287     DOI: 10.1016/j.jocn.2005.10.016

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  11 in total

Review 1.  Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

Authors:  Dustin J Donnelly; Phillip G Popovich
Journal:  Exp Neurol       Date:  2007-06-30       Impact factor: 5.330

2.  Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease.

Authors:  Gjin Ndrepepa; Siegmund Braun; Albert Schömig; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2010-11-05       Impact factor: 5.460

Review 3.  Immunobiology of spinal cord injuries and potential therapeutic approaches.

Authors:  Aabra Ahmed; Arun-Angelo Patil; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2017-09-07       Impact factor: 3.396

Review 4.  β-Blockade use for Traumatic Injuries and Immunomodulation: A Review of Proposed Mechanisms and Clinical Evidence.

Authors:  Tyler J Loftus; Philip A Efron; Lyle L Moldawer; Alicia M Mohr
Journal:  Shock       Date:  2016-10       Impact factor: 3.454

5.  FTY720 reduces inflammation and promotes functional recovery after spinal cord injury.

Authors:  Kangmin D Lee; Woon N Chow; Carmen Sato-Bigbee; Martin R Graf; Robert S Graham; Raymond J Colello; Harold F Young; Bruce E Mathern
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

Review 6.  Extracellular matrix regulation of inflammation in the healthy and injured spinal cord.

Authors:  Andrew D Gaudet; Phillip G Popovich
Journal:  Exp Neurol       Date:  2014-08       Impact factor: 5.330

7.  The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion.

Authors:  Borja Ibanez; Giovanni Cimmino; Susanna Prat-González; Gemma Vilahur; Randolph Hutter; Mario J García; Valentin Fuster; Javier Sanz; Lina Badimon; Juan J Badimon
Journal:  Int J Cardiol       Date:  2009-11-12       Impact factor: 4.164

8.  Pulmonary diesel particulate increases susceptibility to myocardial ischemia/reperfusion injury via activation of sensory TRPV1 and β1 adrenoreceptors.

Authors:  Sarah Robertson; Ashleigh L Thomson; Rod Carter; Holly R Stott; Catherine A Shaw; Patrick W F Hadoke; David E Newby; Mark R Miller; Gillian A Gray
Journal:  Part Fibre Toxicol       Date:  2014-02-25       Impact factor: 9.400

9.  Neutrophil stunning by metoprolol reduces infarct size.

Authors:  Jaime García-Prieto; Rocío Villena-Gutiérrez; Mónica Gómez; Esther Bernardo; Andrés Pun-García; Inés García-Lunar; Georgiana Crainiciuc; Rodrigo Fernández-Jiménez; Vinatha Sreeramkumar; Rafael Bourio-Martínez; José M García-Ruiz; Alfonso Serrano Del Valle; David Sanz-Rosa; Gonzalo Pizarro; Antonio Fernández-Ortiz; Andrés Hidalgo; Valentín Fuster; Borja Ibanez
Journal:  Nat Commun       Date:  2017-04-18       Impact factor: 14.919

Review 10.  Future Perspectives in Spinal Cord Repair: Brain as Saviour? TSCI with Concurrent TBI: Pathophysiological Interaction and Impact on MSC Treatment.

Authors:  Paul Köhli; Ellen Otto; Denise Jahn; Marie-Jacqueline Reisener; Jessika Appelt; Adibeh Rahmani; Nima Taheri; Johannes Keller; Matthias Pumberger; Serafeim Tsitsilonis
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.